An index of small and mid-cap biotechnology stocks listed on US stock exchanges that have one or more drugs in either Phase II or Phase III US FDA clinical trials.
Quick Links
As January 30, 2024 | Index Level | 3-Month | 6-Month | 1-Year | YTD |
Price Return | 7,502.7 | 38.5% | 5.5% | 4.9% | 1.1% |
Total Return | 7,978.3 | 38.5% | 5.5% | 4.9% | 1.1% |
Net Total Return | 7,962.1 | 38.5% | 5.5% | 4.9% | 1.1% |
Index Level | 7,502.7 |
---|---|
3-Month | 38.5% |
6-Month | 5.5% |
1-Year | 4.9% |
YTD | 1.1% |
Index Level | 7,978.3 |
---|---|
3-Month | 38.5% |
6-Month | 5.5% |
1-Year | 4.9% |
YTD | 1.1% |
Index Level | 7,962.1 |
---|---|
3-Month | 38.5% |
6-Month | 5.5% |
1-Year | 4.9% |
YTD | 1.1% |
As of January 30, 2024
Index Symbol (Price Return) | PMBI |
Index Symbol (Total Return) | PMBITR |
Index Symbol (Net Total Return) | PMBINT |
Number of Constituents | 93 |
Market Capitalization | $151 Billion |
Adjusted Market Capitalization | $115 Million |
Rebalancings | Quarterly |
Dividend Yield | 0.00% |
VettaFi's indexes are widely used by financial firms, industry stakeholders and professionals to support a variety of business functions. We offers a range of end-of-day and historical index data subscriptions.
Contact Us